Report Feature
The study includes trends and forecast for the global bioburden testing market by product, test, application, end user, and region as follows:
-
Consumables
- Culture, Media, Reagents, and Kits
- Other Consumables
-
Instrument
- PCR (Polymerase Chain Reaction)
- Microscope
- Other Instruments
By Test [Value ($ Million) shipment analysis for 2014 – 2025]:
- Anaerobic Count Testing
- Mold/Fungi Count Testing
- Aerobic Count Testing
- Spore Count Testing
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Raw Material Testing
- Medical Device Testing
- Sterilization Validation Testing
- Equipment Cleaning Validation
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Pharmaceutical and Biotechnology Companies
- Medical Device Manufacturers
- Contract Manufacturing Organizations
- Manufacturers of Food & Beverage and Agricultural Products
- Microbial Testing Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the bioburden testing companies profiled in this report include Charles River, Merck, SGS, WuXi AppTec, B&D, NAMSA, Nelson Laboratories, Thermo Fisher Scientific, Biomérieux, and Pacific BioLlabs.
Lucintel forecasts that consumables will remain the largest product segment over the forecast period due to their long shelf life and repeat purchase as compared to instruments which are considered one-time investment.
Within this market, contract manufacturing organizations will remain the largest end user segment over the forecast period due to increasing outsourcing of manufacturing processes from pharmaceutical and biotechnology companies.
North America will remain the largest region over the forecast period due to high investments and rapid growth in the pharmaceutical and biotechnology industries in the region.
|
Features of the Global Bioburden Testing Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global bioburden testing market by product (consumables (culture media, reagents, & kits and others) and instrument (PCR, microscope, and others)), test (anaerobic count testing, mold/fungi count testing, aerobic count testing, and spore count testing), application (raw material testing, medical device testing, sterilization validation testing, and equipment cleaning validation), end user (pharmaceutical and biotechnology companies, medical device manufacturers, contract manufacturing organizations, manufacturers of food & beverage and agricultural products, and microbial testing laboratories), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global bioburden testing market? Q.5 What are the business risks and threats to the global bioburden testing market? Q.6 What are emerging trends in this bioburden testing market and the reasons behind them? Q.7 What are some changing demands of customers in this bioburden testing market? Q.8 What are the new developments in this bioburden testing market? Which companies are leading these developments? Q.9 Who are the major players in this bioburden testing market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this bioburden testing market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global bioburden testing market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Consumables and Instrument), Test (Anaerobic Count Testing, Mold/Fungi Count Testing, Aerobic Count Testing, and Spore Count Testing), Application (Raw Material Testing, Medical Device Testing, Sterilization Validation Testing, and Equipment Cleaning Validation), and End User (Pharmaceutical and Biotechnology Companies, Medical Device Manufacturers, Contract Manufacturing Organizations, Manufacturers of Food & Beverage and Agricultural Products, and Microbial Testing Laboratories) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
Methodology
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.